The neuronal versus vascular hypothesis of migraine and cortical spreading depression

Current Opinion in Pharmacology

Volumn 3, Issue 1, 2003, Pages 73-77

  Parsons, Andrew A ^a   Strijbos, Paul J L M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLYCERYL TRINITRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; SILDENAFIL; SUMATRIPTAN;

BRAIN BLOOD VESSEL; BRAIN CIRCULATION; DRUG EFFECT; DRUG MECHANISM; GENE MUTATION; HUMAN; HYPOTHESIS; INFLAMMATION; MIGRAINE; NERVE CELL EXCITABILITY; NONHUMAN; PATHOPHYSIOLOGY; PIA MATER; PRIORITY JOURNAL; REVIEW; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NERVE;

ANIMALS; CEREBROVASCULAR CIRCULATION; HUMANS; MIGRAINE DISORDERS; NEURONS; SPREADING CORTICAL DEPRESSION;

EID: 0037302967     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00016-4     Document Type: Review

References (36)

1. Graham JR, Wolff HG: Mechanism of migraine headache and action of ergotamine tartrate. Arch Meurol Psychiatry 1938, 39:737-763.
2. Ray BS, Wolff HG: Headache studies on headache. Pain sensitive structures of the head andf their significance in headache. Arch Surg 1994, 41:813-856.
3. Leao AAP: Spreading depression of activity in cerebral cortex. J Neurophysiol 1944, 7:359-390.
4. Dreler JP, Kleeberg J, Petzold G, Priller J, Windmüller O, Orzechowski H-D, Lindauer U, Heinemann U, Einhäupl KM, Dimagl U: Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for and endothelial trigger of migrainous aura? Brain 2002, 125:102-112.
5. Akerman S, Willaimson DJ, Kaube H, Goadsby PJ: Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 2002, 137:62-68.
6. Wahl M, Schilling L, Parsons AA, Kaumann A: Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilation elicited by cortical spreading depression. Brain Res 1994, 637:204-210.
7. Colona DM, Meng W, Deal DD, Busija DW: Calcitonin gene-related peptide promotes cerebrovascular dilation during cortical spreading depression in rabbits. Am J Physiol 1994, 266:H1095-H1102.
8. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG: Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002, 22:620-629.
9. Piper RD, Edvinssor L, Ekman R, Lambert GA: Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Cephalalgia 1993, 13:180-183.
10. Moskowitz MA, Nozaki K, Kraig RP: Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993,
11. Hoskin KL, Zagami AS, Goadsby PJ: Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. J Anat 1999, 194:579-588.
12. Kaube H, Hoskin KL, Goadsby PJ: Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia 1992, 12:133-136.
13. Munglani R, Fleming BG, Hunt SP: Remembrance of times past: the significance of c-fos in pain. Br J Anaesth 1996, 76:1-4.
14. Largo C, Cuevas P, Somjen GG, Martin del Rio R, Herreras O: The effect of depressing glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival. J Neurosci 1996, 16:1219-1229.
15. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA: Instrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136-142.
16. Burstein R: Deconstructing migraine headache into peripheral and central sensitization. Pain 2001, 89:107-110.
17. Burstein R, Cutrer MF, Yarnitsky D: The development of cutaneous allodynia during a migraine attack-clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000, 123:173-1709.
18. Read SJ, Hirst WD, Upton N, Parsons AA: Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 2001, 891:69-77.
19. Goadsby PJ, Kaube H, Hosking KL: Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res 1992, 595:167-170.
20. Colonna DM, Meng W, Deal DD, Gowda M, Busija DW: Neuronal NO promotes cerebral cortical hyperemia during cortical spreading depression in rabbits. Am J Physiol 1997, 272:H1315-H1322.
21. Read SJ, Parsons AA: Nitric oxide does not mediate cerebral blood flow changes during cortical spreading depression in the anaesthetised rat. Neurosci Lett 1998, 250:115-118.
22. Read SJ, Smith MI, Hunter AJ, Parsons AA:The dynamics of nitric oxide release measured directly and in real time following repeated waves of cortical spreading depression in the anaethetised cat. Neurosci Lett 1997, 232:127-130.
23. Shen PJ, Gundlach AL: Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD): implications for SD- and NO-mediated neuroprotection. Exp Neurol 1999, 160:317-332.
24. Read SJ, Parsons AA: Sumatriptan modifies cortical free radical release during cortical spreading depression-a novel antimigraine action for sumatriptan? Brain Res 2000, 870:44-53.
25. Obrenovitch TP, Urenjak J, Wang M: Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow Metab 2002, 22:680-688.
26. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J: Nitric oxide synthase inhibition in migraine. Lancet 1997, 349:401-402.
27. Olesen J, Iversen HK, Thomsen LL: Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993, 4:1027-1030.
28. Lambert GA, Donaldson C, Boers PM, Zagami AS: Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res 2000, 887:203-210.
29. Reuter U, Bolay H, Jensen-Olsen I, Chiarugi A, Sanchez del Rio M, Letoumeau R, Theoharides TC, Waeber C, Moskowitz MA: Delayed inflammation in art meninges: implications for migraine pathophysiology. Brain 2001, 124:2490-2502.
30. Reuter U, Chiarugi A, Bolay H, Moskowitz MA: Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol 2002, 51:507-516.
31. Mayevsky A, Doron A, Manor T, Meilin S, Zarchin N, Ouaknine GE: Cortical spreading depression recorded from the human brain using a multiparametric monitoring system. Brain Res 1996, 740:268-274.
32. 7 receptors mediating tachycardia in the cat. Br J Pharmacol 1997, 121:1187-1195.
33. Ophoff RA, Terwindt GM, Vergouwe MN, Frants RR, Ferrari MD: Familial hemiplegic migraine: involvement of a calcium neuronal channel. Neurologia 1997, 12:31-37.
34. Plomp JJ, van den Maagdenberg AM, Molenaar PC, Frants RR, Ferrari MD: Mutant P/Q-type calcium channel electrophysiology and migraine. Curr Opin Investig Drugs 2001, 2:1250-1260.
35. Knight YE, Goadsby PJ: The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 2001, 106:793-800.
36. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC: Brain stem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658-660.